Startups channel feed – Endpoints News

Startups channel feed

Parkinson's transplants emerge as stem cell pioneer Jeanne Loring joins R&D race

6 years ago

Cellarity, Flagship's $50M bet on network biology, marries machine learning and single-cell tech for drug discovery

6 years ago

Perceptive teams up with Chris Garabedian to open up a new, $210M biotech fund focused on A rounds

6 years ago

Jasper Therapeutics launches out of Stanford with new approach to stem cell treatment

6 years ago

Antibody strategy to augment versatile immune cells sparks investment in French biotech

6 years ago

‘Breakthrough’ bladder cancer drug spinout gets $570M to back launch of a new gene therapy in the US

6 years ago

Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets

6 years ago

Cancer Research UK spinoff raises $41M+ in Series B injection

6 years ago

With eyes on a polymer empire prize, French medtech player seals $42M in fresh funding

6 years ago

New cell therapy player launches with $57M from marquee investors to go after 'definitive' tumor targets

6 years ago

New UK startup pursues off-the-shelf CAR-T, cancer vaccines through 'dark antigens'

6 years ago

Some battle tested neuroscience vets are going all out on early onset dementia — with a $44M launch round to build the team

6 years ago

As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential — the RNA editing platform

6 years ago

Vik Bajaj unveils Foresite's new incubator, looking to hatch future giants crossing tech and healthcare

6 years ago

SinoMab BioScience, Alphamab Oncology make their way to the Hong Kong Stock Exchange

6 years ago

Neuroscience biotech led by former Pfizer crew wins $17M to target toxic tau

6 years ago

David Hung is back, launching a new oncology startup with $275M and big ambitions to make news in cancer drug development

6 years ago

The human element: A biotech upstart hopes to carve a path around faulty animal models

6 years ago

Allievex launches with Pappas cash and rare disease drug from BioMarin

6 years ago

Armed with Langer tech and $50M, Verseau hails new checkpoint drugs unleashing macrophages against cancer

6 years ago

Sean Parker helps create a CRISPRed cell therapy 2.0 play — and he’s got a high-profile set of leaders on the team

6 years ago

San Diego upstart debuts discovery engine that puts a twist to protein degradation

6 years ago

Cyteir nets $40M for rad synthetic lethality platform — throwing another monkey wrench at cell repair

6 years ago

Boehringer Ingelheim-backed Abalos tosses hat into packed oncolytic virus ring

6 years ago

First page Previous page 55 56 575859 60 61 Next page Last page